Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Voyager Therapeutics (VYGR) Stock Price & Analysis

1,414 Followers

VYGR Stock Chart & Stats

$1.87$0.15(8.43%)
At close: 4:00 PM EST
$2$2.5$3$3.5Aug 10Aug 24Sep 8Sep 21Oct 5Oct 19Nov 2
Day’s Range
$1.72 - $1.96
52-Week Range
$1.68 - $5.48
Previous Close
$1.72
Volume
N/A
Average Volume (3M)
963.60K
Market Cap
$115.23M
Enterprise Value
$128.15M
Total Cash (Recent Filing)
$106.81M
Total Debt (Recent Filing)
$30.51M
Price to Earnings (P/E)
―
Beta
1.49
Next Earnings
Mar 09, 2027 (Est.)
EPS Estimate
-0.35
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Manageable Leverage

Relatively low leverage gives Voyager more financial flexibility than a heavily indebted biotech, allowing it to direct capital toward neurological programs and absorb operational volatility without the immediate burden of substantial debt servicing.

High Gross Margin

The reported gross margin indicates that Voyager’s underlying products and related activities can generate substantial gross profit before operating expenses. If revenue scales through successful programs, this margin profile could support stronger operating leverage over time.

Extended Cash Runway

Extending the cash runway reduces near-term funding pressure and gives Voyager more time to advance VY7523 and VY1706 toward important clinical milestones. This improves execution flexibility while the company develops its neurological medicine pipeline.

Bears Say

Declining Revenue

A substantial decline in trailing revenue signals weakening current commercial or partnered activity and reduces the resources available to fund research internally. Continued contraction would make it harder for Voyager to cover its fixed operating base and support pipeline advancement.

Persistent Cash Burn

Large negative operating and free cash flow shows that Voyager is consuming significant cash in its current operating model. Unless revenue, partnerships, or expenses change materially, continued burn could require external funding and constrain strategic choices.

Volatile Profitability

The shift from strong profitability to substantial losses demonstrates that Voyager’s earnings profile remains highly volatile. Such inconsistency makes internal funding less dependable and increases the importance of successful development milestones or improved operating discipline.

Voyager Therapeutics News

VYGR FAQ

What was Voyager Therapeutics’s price range in the past 12 months?
Voyager Therapeutics lowest stock price was $1.68 and its highest was $5.48 in the past 12 months.
What is Voyager Therapeutics’s market cap?
Voyager Therapeutics’s market cap is $115.23M.
When is Voyager Therapeutics’s upcoming earnings report date?
Voyager Therapeutics’s next earnings report is estimated for Mar 09, 2027 (not yet confirmed), which is in 122 days.
How were Voyager Therapeutics’s earnings last quarter?
Voyager Therapeutics released its earnings results on Nov 05, 2026. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.419 by $0.019.
Is Voyager Therapeutics overvalued?
According to Wall Street analysts Voyager Therapeutics’s price is currently Undervalued.
Does Voyager Therapeutics pay dividends?
Voyager Therapeutics does not currently pay dividends.
What is Voyager Therapeutics’s EPS estimate?
Voyager Therapeutics’s EPS estimate is -0.35.
How many shares outstanding does Voyager Therapeutics have?
Voyager Therapeutics has 61,617,947 shares outstanding.
What happened to Voyager Therapeutics’s price movement after its last earnings report?
Voyager Therapeutics reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.419. Following the earnings report the stock price went up 8.43%.
Which hedge fund is a major shareholder of Voyager Therapeutics?
Hedge funds hold Voyager Therapeutics shares: the largest hedge-fund position in Voyager Therapeutics is 71,888,378 shares, and hedge funds decreased their holdings by 590.3K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology